Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Teresa L. Young Insider Profile
4 Followers
Teresa L. Young, EVP, Chief Commercial & Strategy Officer at Seres Therapeutics, holds 88.48K shares in Seres Therapeutics (Ticker: MCRB).
Teresa L. Young has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Teresa L. Young's holdings
Insider Roles
EVP, Chief Commercial & Strategy Officer
Roles that Teresa L. Young holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Teresa L. Young
Teresa L. Young's Trading History
List of latest transactions for each holding click on a transaction to see Teresa L. Young's performance on stock
You May Also Like
Teresa L. Young insider profile FAQ
What is the percentage of profitable transactions made by Teresa L. Young?
The percentage of profitable transactions made by Teresa L. Young is ―.
What is the average return per transaction made by Teresa L. Young?
The average return per transaction made by Teresa L. Young is ―.
What stocks does Teresa L. Young hold?
Teresa L. Young holds: MCRB stocks.
What was Teresa L. Young’s latest transaction?
Teresa L. Young latest transaction was an Uninformative Buy of $5.90K.
What was Teresa L. Young's most profitable transaction?
Teresa L. Young’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Teresa L. Young's role in Seres Therapeutics?
Teresa L. Young's role in Seres Therapeutics is EVP, Chief Commercial & Strategy Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.